Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

New analgesic agents imparted in recent patents

March 29, 2006

Additional treatment and switching therapy effective in treating resistant depression

March 29, 2006

Lundbeck begins phase I trials for Lu-AA34893 for depression

March 29, 2006

FemmePharma opens IND for topical cream to treat breast pain

March 29, 2006

A novel target to improve memory: ghrelin

March 28, 2006

Lyrica receives European approval for GAD

March 28, 2006

Rectogesic completes E.U. mutual recognition procedure

March 28, 2006

New dosages of Risperdal M-TAB now available

March 28, 2006

Phase II data for ALGRX-4975 in hernia repair at odds with other phase II results

March 28, 2006

Paion begins program for next-generation plasminogen activators

March 28, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...